EUVIMEDEUVIMED entdecken
Editorial

Balancing the evidence with the SPAQI recommendations: from perioperative discontinuation towards continuation of SGLT2 inhibitors

Bruno Garcia, Anjali A Dixit, Matthieu Legrand

British Journal of Anaesthesia · 2026-08 · 137 (2) · 413-419

DOI: 10.1016/j.bja.2026.05.005 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Anaesthesia, 2026-08. Verfasst von Bruno Garcia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Saint-Pierre University Hospital, Université libre de Bruxelles (ULB), Brussels, Belgium; French Clinical Research Infr…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Perioperative Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Society for Perioperative Assessment and Quality Improvement consensus recommends a perioperative management strategy for sodium-glucose cotransporter 2 inhibitors based on surgical type, metabolic context, and underlying indication. This risk-stratified approach balances the low but real risk of euglycaemic ketoacidosis against established cardio-renal benefits. Current evidence is limited and suggests that euglycaemic ketoacidosis is driven more by metabolic context, particularly diabetes mellitus and fasting, than by drug continuation alone. Importantly, discontinuation could lead to a loss of cardiovascular benefit, whereas emerging data suggest potential perioperative benefits, although evidence remains limited. Overall, these recommendations shift toward a strategy based on euglycaemic ketoacidosis risk factors and careful metabolic monitoring rather than systematic discontinuation pending large randomised controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsPerioperative CareHumansKetosisTreatment InterruptionPractice Guidelines as Topic

Stichwörter der Autor:innen

cardiac surgerydiabetes mellituseuglycaemic ketoacidosisgliflozinsnoncardiac surgerysodium-glucose cotransporter 2 inhibitors

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Intensive Care, Saint-Pierre University Hospital, Université libre de Bruxelles (ULB), Brussels, Belgium; French Clinical Research Infrastructure Network-Cardiovascular and Renal Clinical Trialists (FCRIN…
  • Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • French Clinical Research Infrastructure Network-Cardiovascular and Renal Clinical Trialists (FCRIN INI-CRCT), Nancy, France; Department of Anesthesia & Perioperative Care, Division of Critical Care Medicine, University…

Förderung

  • NIH

Zitieren

APA

Garcia, B., Dixit, A. A., & Legrand, M. (2026). Balancing the evidence with the SPAQI recommendations: from perioperative discontinuation towards continuation of SGLT2 inhibitors. British Journal of Anaesthesia, 137(2), 413-419. https://doi.org/10.1016/j.bja.2026.05.005

Vancouver

Garcia B, Dixit AA, Legrand M. Balancing the evidence with the SPAQI recommendations: from perioperative discontinuation towards continuation of SGLT2 inhibitors. British Journal of Anaesthesia. 2026;137(2):413-419. doi:10.1016/j.bja.2026.05.005

BibTeX
@article{Garcia2026,
  author = {Garcia, Bruno and Dixit, Anjali A and Legrand, Matthieu},
  title = {Balancing the evidence with the SPAQI recommendations: from perioperative discontinuation towards continuation of SGLT2 inhibitors},
  journal = {British Journal of Anaesthesia},
  year = {2026},
  volume = {137},
  number = {2},
  pages = {413--419},
  doi = {10.1016/j.bja.2026.05.005}
}
Kostenlos starten →